Nicoletta Brega
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Hematology top 2%
- Cancer Research top 10%
- Co-authors
- P. ScigallaCarlo L. BelloGiorgio MassiminiJean‐Pierre ArmandÉric RaymondCatherine DelbaldoCaroline RobertKarina Vera
- Topics
- Lung Cancer Treatments and Mutations (30 papers)Colorectal Cancer Treatments and Studies (21 papers)Glioma Diagnosis and Treatment (6 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Nicoletta Brega
50 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 995
- Oncology 825
- Pulmonary and Respiratory Medicine 804
- Hematology 601
- Cancer Research 301
Countries citing papers authored by Nicoletta Brega
This map shows the geographic impact of Nicoletta Brega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicoletta Brega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicoletta Brega more than expected).
Fields of papers citing papers by Nicoletta Brega
This network shows the impact of papers produced by Nicoletta Brega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicoletta Brega. The network helps show where Nicoletta Brega may publish in the future.
Co-authorship network of co-authors of Nicoletta Brega
This figure shows the co-authorship network connecting the top 25 collaborators of Nicoletta Brega. A scholar is included among the top collaborators of Nicoletta Brega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicoletta Brega. Nicoletta Brega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 11 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | 13 | |
| 9 | 5 | |
| 10 | 27 | |
| 11 | 1 | |
| 12 | 40 | |
| 13 | 16 | |
| 14 | 1 | |
| 15 | 26 | |
| 16 | 36 | |
| 17 | 107 | |
| 18 | 18 | |
| 19 | 2 | |
| 20 | Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancerbreakdown → | 934 |
About Nicoletta Brega
Nicoletta Brega is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Colorectal Cancer Treatments and Studies (21 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Hematology (601 citations), Oncology (825 citations) and Genetics (279 citations). Nicoletta Brega has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include P. Scigalla, Carlo L. Bello, Giorgio Massimini, Jean‐Pierre Armand, Éric Raymond, Catherine Delbaldo, Caroline Robert, Karina Vera, Nathalie Lassau and Sandrine Faivre. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.